Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-18-018711)

Filing Details

Accession Number:: 0001209191-18-018711
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-03-12 08:52:27
Reporting Period:: 2018-03-08

Accepted Time:: 2018-03-12 08:52:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1178253	Scynexis Inc	SCYX	Pharmaceutical Preparations (2834)	562181648

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1237401	C David Hastings	101 Hudson Street Suite 3610 Jersey City NJ 07302		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-03-08	11,834	$1.69	31,834	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrant (right to buy)	Acquisiton	2018-03-08	8,875	$0.00	8,875	$1.85
Common Stock	Common Stock Warrant (right to buy)	Acquisiton	2018-03-08	5,325	$0.00	5,325	$2.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
8,875	2018-03-08	2019-03-14	No	4	P	Direct
5,325	2018-03-08	2023-03-08	No	4	P	Direct

Footnotes

Reflects the purchase on March 8, 2018, of 11,834 shares of the issuer's common stock, par value $0.001 per share, at a public offering price of $1.69 per share of common stock and accompanying warrants to purchase 0.75 of a share of common stock (Series 1 warrant) and 0.45 of a share of common stock (Series 2 warrant).